Introduction
Continuous positive airway pressure (CPAP) refers to the application of positive pressure on a spontaneously breathing neonate. This has become a popular and effective therapy in management of idiopathic respiratory distress syndrome (IRDS) in the premature neonate. Being technically simple, non-invasive, less damaging to the neonatal lung and low cost, CPAP has rapidly gained popularity over ventilators both in the developing and developed countries. At present CPAP appears to be the ideal solution for management of mild to moderate degrees of IRDS in the newborn.
Background
The first clinical use of CPAP was reported in 1971 1 . Though initially described with endotracheal application, the use of nasal prongs to deliver CPAP successfully soon followed. After almost a decade of enthusiastic clinical use, CPAP fell out of favour in early 1980s with the advent of newer modes of mechanical ventilation. After 15 years of ventilator predominance in the management of IRDS, the efficacy and protective value of CPAP was brought to light with the reports from Columbia University unit. Since then CPAP has retained its popularity as the treatment of choice for mild to moderate IRDS.
Components of a CPAP system
Components of a CPAP system essentially consist of: 2 . Nasal cannulae fail to deliver optimum CPAP, due to leakage around nostrils, inadequate humidity, inability to monitor the pressures delivered and inability to control oxygen independently. Nasal masks are not successful due to difficulty in maintaining an adequate seal and its tendency to obstruct the airway 3 . Meta analyses have shown that binasal prongs are the most effective 4 . Endotracheal tube, face mask and head box are no longer considered as suitable for delivery of CPAP 5 .
Effects of CPAP on the neonate
Physiological benefits on the lung CPAP predominantly helps by splinting the airways, thus preventing atelectasis and collapse. This allows better recruitment of alveoli, thereby increasing the functional residual capacity (FRC). Additionally, there is improved compliance, decreased airway resistance, conservation of surfactant and stabilization of chest and diaphragm in the extremely premature baby 6 .
Effect on arterial blood gases (ABGs)
CPAP improves oxygen by increasing the FRC. With moderate CPAP of 4-6 cm water, arterial carbon dioxide (CO 2 ) improves due to recruitment of alveoli creating a larger surface area for gas exchange. With further increase in CPAP pressure, over-distension of alveoli with incomplete gas emptying causes retention of CO 2 .
Indications for CPAP application
Clinical situations CPAP is the treatment of choice for mild to moderate degrees of IRDS and apnoea of prematurity. It is strongly indicated in extubation from IPPV. Its other uses are congenital pneumonia, TTN/Delayed adaptation and meconium aspiration syndrome (MAS).
Assessment criteria
Respiratory distress with a Silverman score of 4-6, tachypnoea >60 per minute or needing >55% FiO 2 to maintain satisfactory pulse oxymetry are considered as clinical indicators to initiate CPAP.
Biochemical criteria
Unsatisfactory ABGs with pCO 2 >55mmHg and/or pO 2 <60 mmHg while on 3L/min of oxygen (O 2) via head box (approximately 60% FiO 2 ) are considered biochemical indicators to initiate CPAP.
Contraindications for CPAP
CPAP is contraindicated in neonates with congenital diaphragmatic hernia, tracheo-oesophageal fistula, choanal atresia, cleft palate, poor respiratory efforts and severe cardiovascular instability 7 .
Guidelines for CPAP therapy
Timing of CPAP application CPAP mainly helps by splinting the airways thus preventing atelectasis and alveolar collapse. To be of optimal benefit CPAP should be started as early as possible when indicated.
Place of prophylactic CPAP
While CPAP should be started as early as possible when indications are evident, it has been established that there is no additional benefit of prophylactic CPAP on preterm babies without clinical or biochemical evidence of IRDS. In fact, there are concerns regarding increased adverse effects such as lung injury, air leak syndromes and intraventricular haemorrhage. Hence prophylactic CPAP is not recommended at present 8 .
Initiation for CPAP and stepping up of support CPAP should be started with a pressure of 4-6 cm water and 40-50% of FiO 2 . If oxygenation is unsatisfactory, pressure should be gradually increased by 1-2 cm water at a time, up to 7-8 cm water. Then FiO 2 may be gradually increased by 5% at a time up to 60%. The aim is to achieve a comfortable baby with satisfactory pulse oxymetry and ABGs. 6 . In the absence of transcutaneous CO 2 monitoring, an ABG to establish acceptable CO 2 levels and close observation for changes in the respiratory pattern is essential.
Monitoring during CPAP application

CPAP & surfactant therapy
Surfactant therapy for babies on CPAP is an established procedure in the management of IRDS. This expensive therapeutic option is most beneficial and cost effective when implemented in premature babies <30 weeks and in neonates who need higher range of oxygen and CPAP pressures. While on CPAP the baby is briefly disconnected, intubated, given the calculated amount of surfactant and extubated back on to CPAP. This is known as "INSURE" method (Intubation-SurfactantExtubation) & is widely and successfully practised 9 .
CPAP in different clinical situations
IRDS
CPAP is the gold standard management in mild to moderate IRDS. Early application of CPAP reduces the need for IPPV in a significant proportion of premature neonates with IRDS. In fact, there is research to support that perinatal morbidity is less in extremely premature neonates between 24 to 27 weeks gestation when CPAP is initiated in the labour room than when surfactant followed by IPPV is initiated within one hour of birth 9 .
Recurrent apnoeic episodes
Apnoea of prematurity as well as obstructive apnoea and apnoea secondary to respiratory causes can be effectively treated by CPAP in most instances. In apnoea of prematurity methyl xanthines should be tried initially.
Post-extubation from IPPV
CPAP provided immediately after extubation from IPPV is recommended to prevent post extubation atelectasis, apnoea and respiratory acidosis.
Delayed adaptation/TTN
This condition is thought to be due to excess lung fluid. Usually the baby is term or near term and the respiratory distress is mild to moderate. If started early, CPAP helps in maintaining lung expansion. Generally CPAP can be weaned off within 72 hours.
Pneumonia CPAP is indicated in stable neonates with mild to moderate pneumonia. It helps by maintaining lung expansion preventing any collapse due to secretions.
Meconium aspiration syndrome (MAS)
Nasal CPAP of 4-7 cm of water may be helpful, but further increase in CPAP pressure may lead to overdistension and air leak. MAS occurs in term babies and nasal prongs/cannula may make the baby very restless leading to more harm than good.
Other indications CPAP is of benefit in post-surgical situations, laryngomalacia and bronchomalacia.
Adverse Effects of excessive CPAP
CPAP when cautiously used is safe and usually causes no adverse effects. When used at inappropriately high pressures it may pose several unwanted effects 6 :
Cardiovascular: Reduction in cardiac output, increased central venous pressure, increased pulmonary vascular resistance.
Pulmonary: Pulmonary air leaks are the commonest clinically significant adverse effect of CPAP 11 . Overdistension and diminished compliance are other side effects noted. Recent trials have shown an increase in the incidence of pneumothorax 12, 13 .
CNS:
Increased intracranial pressure and decreased cerebral perfusion.
GIT: Bowel distension and decreased GI blood flow.
Renal: Diminished renal blood flow.
Local adverse effects of CPAP application: These are usually due to application of too much pressure on the nostrils or using too tight nasal prongs. They manifest as peri-nasal excoriation, scarring, pressure necrosis & septal distortion 14, 15 . CPAP failure is also seen in 60% of extremely low birth weight neonates less than 700g 14 . It is appropriate to have a low threshold to apply IPPV on extremely premature babies <27 weeks with birth weights less than 700g.
Failure of CPAP
Weaning from CPAP
Weaning from CPAP should be guided by maintenance of clinical stability and satisfactory pulse oximetry. Research comparing different strategies of weaning has shown that gradual stepping down of CPAP pressure, judged by clinical stability is more effective than time controlled weaning 16 . CPAP pressure should be reduced by 1-2 cm water decrements and FiO 2 reduced by 5-10% decrements. When CPAP pressure reaches 3-4 and FiO 2 <40% baby may be changed to head box oxygen.
Common concerns regarding CPAP Application
Optimal positioning on CPAP Any reasonable positioning is acceptable to deliver CPAP effectively, but semi-prone or prone position will minimize central and obstructive apnoea 3 .
Is mouth closing important?
Although there is a theoretical benefit of mouth closure in preserving the pharyngeal pressure, successes of CPAP in most studies have been shown without any measures to keep the mouth obliterated. Hence mouth closure is not recommended 3 .
Gaseous distension of stomach and CPAP
It is not a common problem with CPAP. If gaseous distension occurs, the orogastric tube end may be kept open at a level higher than the baby's head to vent the gas 3 .
Successful application of CPAP and chronic lung disease (CLD)
Research has shown that there is no difference in the incidence of CLD/bronchopulmonary dysplasia (BPD) or mortality between extremely premature babies managed with early CPAP and invasive modes of ventilation. Some research even shows a better morbidity in the CPAP group 13 .
Other modes of non invasive respiratory support
Several modes of non invasive ventilation (NIV), which combine nasal continuous positive airway pressure (NCPAP) effect with superimposed ventilator breaths are being used currently in many centres. Nasal intermittent positive pressure ventilation (NIPPV) which may be mandatory or synchronized and nasopharyngeal intermittent mandatory or synchronized ventilation (NPIMV/NPSIPPV) are some of the newly introduced modes. Many studies have shown that there is a benefit in NIPPV in reducing the incidence of apnoea of prematurity and extubation failures when compared with CPAP [17] [18] [19] [20] . . However, some researches indicate that early NIPPV does not decrease the need for mechanical ventilation when compared with NCPAP, in the first 72 hours of life 21 .
